Matinas BioPharma Receives NYSE Noncompliance Notice
January 10, 2025 17:15 ET | Source: Matinas BioPharma Holdings, Inc. BEDMINSTER,…
Matinas BioPharma Receives NYSE Noncompliance Notice
January 10, 2025 17:15 ET | Source: Matinas BioPharma Holdings, Inc. BEDMINSTER,…
AEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public Offering
January 06, 2025 09:00 ET | Source: AEON Biopharma IRVINE, Calif., Jan.…
AEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public Offering
January 06, 2025 09:00 ET | Source: AEON Biopharma IRVINE, Calif., Jan.…
AEON Biopharma, Inc. Announces Launch of Proposed Public Offering
January 03, 2025 20:02 ET | Source: AEON Biopharma IRVINE, Calif., Jan.…
AEON Biopharma, Inc. Announces Launch of Proposed Public Offering
January 03, 2025 20:02 ET | Source: AEON Biopharma IRVINE, Calif., Jan.…
AEON Biopharma, Inc. Announces Launch of Proposed Public Offering
January 03, 2025 20:02 ET | Source: AEON Biopharma IRVINE, Calif., Jan.…
Tevogen Bio to Host Panel Discussions AI In Biopharma: Next Frontier of Medical Innovation and Pioneering the Economics of Health: Balancing Access and Outcomes During J.P. Morgan Healthcare Conference
The JPM Healthcare Conference is the largest and most informative health care…
LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China
December 12, 2024 19:57 ET | Source: LakeShore Biopharma Co., Ltd BEIJING,…
Kaida BioPharma Announces Formation of Scientific Advisory Board to Support Development of KAD101 for Ovarian Cancer
Company appoints Anil K. Sood, MD, as inaugural member Company continues to…